Costantino De Renzis

About

Dr. Costantino De Renzis is a leading figure in radiation oncology, specializing in stereotactic body radiotherapy (SBRT) and radiosurgery, with a particular focus on robotic platforms like CyberKnife. His major contributions center on advancing non-invasive, high-precision treatments for prostate cancer and brain metastases. A landmark study, "High-Dose Robotic Stereotactic Body Radiotherapy in the Treatment of Patients With Prostate Cancer" (21 citations), demonstrated that SBRT can effectively emulate the dose fractionation of high-dose-rate brachytherapy, offering a less invasive alternative for localized prostate cancer. His work on prognostic factors in brain metastases, analyzing 223 patients (14 citations), has helped refine patient selection for radiosurgery. Additionally, his early review "CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System" (13 citations) helped establish the clinical rationale for robotic radiosurgery in urologic oncology. Through these studies, Dr. De Renzis has contributed to expanding the therapeutic role of stereotactic techniques, improving outcomes while reducing treatment-related toxicity.

Research Focus

Key Achievements

Top Papers

1. 1
   High-Dose Robotic Stereotactic Body Radiotherapy in the Treatment of Patients With Prostate Cancer

   21 citations · 2015
2. 2
   Prognostic factors in patients treated with stereotactic image-guided robotic radiosurgery for brain metastases: a single-center retrospective analysis of 223 patients

   14 citations · 2016
3. 3
   CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System

   13 citations · 2009

Key Collaborators

Contact & Links